Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics

Ann Rheum Dis. 2005 May;64(5):793-4. doi: 10.1136/ard.2004.028167.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / genetics*
  • Drug Resistance / genetics
  • Humans
  • Infliximab
  • Middle Aged
  • Polymorphism, Genetic*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab